Skip to main content
SpringerLink
Log in

Rotavirus W179-9 Vaccine (Merck and Co)

  • Section 2: Prophylactic Anti-Infective Vaccines
  • Adis R&D Profile
  • Published:
Drugs in R & D Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Treanor JJ, Clark HF, Pichichero M, et al. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. Pediatr Infect Dis J 1995 Apr; 14: 301–7

    Article  PubMed  CAS  Google Scholar 

  2. Christy C, Offit P, Clark HF, et al. Evaluation of a bovine-human rotavirus reassortant vaccine in infants. J Infect Dis 1993 Dec; 168: 1598–9

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rotavirus W179-9 Vaccine (Merck and Co). Drugs R&D 2, 220–221 (1999). https://doi.org/10.2165/00126839-199902030-00018

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00126839-199902030-00018

Keywords

Search

Navigation